Purchase Price Allocation (ASC 805 | IFRS 3)

Address reporting challenges in business transactions and mitigate any future impairment risks

With primary objective of bringing more transparency to reporting of acquisitions, the ASC805 “Business Combinations” requires companies to allocate the purchase consideration paid in M&A transaction into various tangible and intangible assets at their fair value.

Complying with reporting requirements of the standard can pose significant challenges to CFO – both from perspective of time involvement as well confronting complex provisions to avoid any misreporting.

Aranca has experience of successfully completing hundreds of purchase price allocation assignments across diverse industry sectors and deal sizes.

With our in-house team of patent experts and extensive data sources at disposal, our valuation team is able to address all the key issues impacting value of intangible assets.

Select PPA Engagements

GuestLogix, Inc.

GuestLogix, Inc.

Kabouter Management

Provided ASC805 purchase price allocation in connection with acquisition of Open Jaw Technologised

Ballard Power Systems

Ballard Power Systems

Top Ace Asset Management

Provided ASC805 purchase price allocation in connection with acquisition of Protonex Technology Corporation

ConnectYourCare, Inc.

ConnectYourCare, Inc.

ABS Capital

Provided ASC805 purchase price allocation in connection with acquisition of ConnectYourCare, LLC by ABS Capital

SportsMedia

SportsMedia

Vicente Capital Partners

Provided ASC805 purchase price allocation in connection with acquisition of Information and Display Systems (IDS) by Sports Media.

Komli Media, Inc.

Komli Media, Inc.

Nexus India Capital, Draper Fisher Juvetson, Northwest Venture Partners

Provided ASC805 purchase price allocation in connection with acquisition of ADMAX Network Holdings Ltd.

Dachis Corporation

Dachis Corporation

Austin Ventures, LMIA Coinvestment LLC

Provided ASC805 purchase price allocation in connection with acquisition of Xplane

KaloBios Pharmaceuticals, Inc.

KaloBios Pharmaceuticals, Inc.

Fidelity Investments, Baxter Healthcare

Provided ASC805 purchase price allocation in connection with acquisition of Celscia Therapeutics, Inc.

Yatra.com

Yatra.com

Norwest Venture Partners, Intel Capital

Provided ASC805 purchase price allocation in connection with acquisition of Travelguru.com

Why Aranca?


cap-block-icon1

Expertise

250+ PPA assignments across industry sectors

Experience of valuing diverse intangibles including patents, customer-relationships, brand, trademarks, etc.

cap-block-icon2

Patent Research Capabilities

30+ patent experts across technology domains who work with global clients providing research & advisory services spanning entire patent life-cycle.

cap-block-icon2

Audit Review Support

We proactively engage with your auditors and support you throughout the engagement to complete the exercise in credible and timely manner.

What Our Clients Say

"I must compliment you for the outstanding job you did on our PPA assignment. The report was of high quality and you managed to adhere to short time lines. It is difficult to find responsive and knowledgeable firms that can also offer competitive cost advantage."

CFO, A leading CRM Software firm

"Aranca did a very comprehensive job in performing a valuation of our company. The team was extremely responsive and professional. Our investors said that the report that Aranca wrote was among the best that they had seen for any of their portfolio companies."

Finance Head, Aryaka Networks Inc.

"I must compliment you for the outstanding job you did on our PPA assignment. The report was of high quality and you managed to adhere to short time lines. It is difficult to find responsive and knowledgeable firms that can also offer competitive cost advantage."

CFO, Dachis Group

"Thanks for all of your efforts and commitment to our project. The team did a great job in a short period of time, and I really appreciate it! I’ve worked with multiple business valuations firms in my past, and the job that your team did was by far the best."

CFO, Leading US ecommerce platform

"Aranca did a great job on the 409A report for us. The analysis was extremely thorough and the report was of the highest quality. Greatly exceeded expectations! Thank you."

Senior VP & CFO, New Leaf Symbiotics

"We have had a few valuations done by Aranca. [There were] absolutely no problems with the reports; we have a very complicated cap structure and have filed an S-1. The SEC has reviewed and blessed the results and the supporting report. These were done expertly and at a very competitive price."

Partner, Legal Counsel Firm

"We were looking to accurately and effectively assess and evaluate our IP portfolio to commercialize our assets better or raise funds. We needed experts who understood technical aspects of the patents to determine value with respect to the competitive landscape, and also be able to translate it into a comprehensive but easy to understand financial analysis for potential investors and third-parties. That’s why, we chose Aranca because of its blend of strong Intellectual Property research and valuation capabilities.

The Aranca team was extremely professional, thorough and collaborative while working with our in-house team. We were kept in complete sync during the project engagement, as Aranca conducted the technology strength assessment and built a comprehensive valuation report with detailed market analysis and financial forecasts. To our delight, the team went the extra mile to handle our project deftly, and ensured our needs were completely met. We would score Aranca an ’11 out of 10’ for this project."

Stephen Burnett, Co-Founder & CEO, Koolbridge Solar, Inc.

Knowledge Library


  1. 1
  2. 2
  3. 3
    1
  1. 2